Southeastern Dialysis Davita Whiteville is a medicare approved dialysis facility center in Whiteville, North Carolina and it has 26 dialysis stations. It is located in Columbus county at 608 Pecan Lane, Whiteville, NC, 28472. You can reach out to the office of Southeastern Dialysis Davita Whiteville at (910) 642-0233. This dialysis clinic is managed and/or owned by Davita. Southeastern Dialysis Davita Whiteville has the following ownership type - Profit. It was first certified by medicare in April, 1986. The medicare id for this facility is 342521 and it accepts patients under medicare ESRD program.
| Name | Southeastern Dialysis Davita Whiteville |
|---|---|
| Location | 608 Pecan Lane, Whiteville, North Carolina |
| No. of Dialysis Stations | 26 |
| Medicare ID | 342521 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 608 Pecan Lane, Whiteville, North Carolina, 28472 | |
| (910) 642-0233 | |
News Archive
In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond Soccio, MD, PhD, and colleagues at the Perelman School of Medicine at the University of Pennsylvania, aim to apply this knowledge to develop personalized approaches to treating diabetes and other metabolic disorders.
"You are what you eat," the saying goes, but is what you eat playing a role in how much you sleep? Sleep, like nutrition and physical activity, is a critical determinant of health and well-being. With the increasing prevalence of obesity and its consequences, sleep researchers have begun to explore the factors that predispose individuals to weight gain and ultimately obesity.
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
The Los Angeles Times: "The House voted 419 to 0 on Wednesday to approve new benefits and financial support for the primary live-in caregivers of seriously wounded veterans who served in the wars in Iraq and Afghanistan. The measure, which would cost about $1.7 billion over five years, is part of comprehensive legislation that would permit the Department of Veterans Affairs to expand its assistance to family members of veterans generally." The bill calls for rates on a par with "commercial rates for home caregivers" (Tan, 4/21).
› Verified 7 days ago
| NPI Number | 1023077443 |
| Organization Name | Southeastern Dialysis Center Whiteville |
| Doing Business As | Total Renal Care Of North Carolina Llc |
| Address | 608 Pecan Ln Whiteville, North Carolina, 28472 |
| Phone Number | (910) 642-0233 |
News Archive
In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond Soccio, MD, PhD, and colleagues at the Perelman School of Medicine at the University of Pennsylvania, aim to apply this knowledge to develop personalized approaches to treating diabetes and other metabolic disorders.
"You are what you eat," the saying goes, but is what you eat playing a role in how much you sleep? Sleep, like nutrition and physical activity, is a critical determinant of health and well-being. With the increasing prevalence of obesity and its consequences, sleep researchers have begun to explore the factors that predispose individuals to weight gain and ultimately obesity.
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
The Los Angeles Times: "The House voted 419 to 0 on Wednesday to approve new benefits and financial support for the primary live-in caregivers of seriously wounded veterans who served in the wars in Iraq and Afghanistan. The measure, which would cost about $1.7 billion over five years, is part of comprehensive legislation that would permit the Department of Veterans Affairs to expand its assistance to family members of veterans generally." The bill calls for rates on a par with "commercial rates for home caregivers" (Tan, 4/21).
› Verified 7 days ago
| Dialysis patients with Hemoglobin data | 42 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 21 |
News Archive
In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond Soccio, MD, PhD, and colleagues at the Perelman School of Medicine at the University of Pennsylvania, aim to apply this knowledge to develop personalized approaches to treating diabetes and other metabolic disorders.
"You are what you eat," the saying goes, but is what you eat playing a role in how much you sleep? Sleep, like nutrition and physical activity, is a critical determinant of health and well-being. With the increasing prevalence of obesity and its consequences, sleep researchers have begun to explore the factors that predispose individuals to weight gain and ultimately obesity.
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
The Los Angeles Times: "The House voted 419 to 0 on Wednesday to approve new benefits and financial support for the primary live-in caregivers of seriously wounded veterans who served in the wars in Iraq and Afghanistan. The measure, which would cost about $1.7 billion over five years, is part of comprehensive legislation that would permit the Department of Veterans Affairs to expand its assistance to family members of veterans generally." The bill calls for rates on a par with "commercial rates for home caregivers" (Tan, 4/21).
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 74 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 585 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond Soccio, MD, PhD, and colleagues at the Perelman School of Medicine at the University of Pennsylvania, aim to apply this knowledge to develop personalized approaches to treating diabetes and other metabolic disorders.
"You are what you eat," the saying goes, but is what you eat playing a role in how much you sleep? Sleep, like nutrition and physical activity, is a critical determinant of health and well-being. With the increasing prevalence of obesity and its consequences, sleep researchers have begun to explore the factors that predispose individuals to weight gain and ultimately obesity.
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
The Los Angeles Times: "The House voted 419 to 0 on Wednesday to approve new benefits and financial support for the primary live-in caregivers of seriously wounded veterans who served in the wars in Iraq and Afghanistan. The measure, which would cost about $1.7 billion over five years, is part of comprehensive legislation that would permit the Department of Veterans Affairs to expand its assistance to family members of veterans generally." The bill calls for rates on a par with "commercial rates for home caregivers" (Tan, 4/21).
› Verified 7 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Southeastern Dialysis Davita Whiteville with elevated calcium levels.
| Patients with hypercalcemia | 76 |
| Hypercalcemia patient months | 598 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 77 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 27 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 33 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 18 |
| Patients with Serumphosphor greater than 7 mg/dL | 11 |
News Archive
In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond Soccio, MD, PhD, and colleagues at the Perelman School of Medicine at the University of Pennsylvania, aim to apply this knowledge to develop personalized approaches to treating diabetes and other metabolic disorders.
"You are what you eat," the saying goes, but is what you eat playing a role in how much you sleep? Sleep, like nutrition and physical activity, is a critical determinant of health and well-being. With the increasing prevalence of obesity and its consequences, sleep researchers have begun to explore the factors that predispose individuals to weight gain and ultimately obesity.
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
The Los Angeles Times: "The House voted 419 to 0 on Wednesday to approve new benefits and financial support for the primary live-in caregivers of seriously wounded veterans who served in the wars in Iraq and Afghanistan. The measure, which would cost about $1.7 billion over five years, is part of comprehensive legislation that would permit the Department of Veterans Affairs to expand its assistance to family members of veterans generally." The bill calls for rates on a par with "commercial rates for home caregivers" (Tan, 4/21).
› Verified 7 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 85 |
| Patient months included in arterial venous fistula and catheter summaries | 517 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 56 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 14 |
News Archive
In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond Soccio, MD, PhD, and colleagues at the Perelman School of Medicine at the University of Pennsylvania, aim to apply this knowledge to develop personalized approaches to treating diabetes and other metabolic disorders.
"You are what you eat," the saying goes, but is what you eat playing a role in how much you sleep? Sleep, like nutrition and physical activity, is a critical determinant of health and well-being. With the increasing prevalence of obesity and its consequences, sleep researchers have begun to explore the factors that predispose individuals to weight gain and ultimately obesity.
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
The Los Angeles Times: "The House voted 419 to 0 on Wednesday to approve new benefits and financial support for the primary live-in caregivers of seriously wounded veterans who served in the wars in Iraq and Afghanistan. The measure, which would cost about $1.7 billion over five years, is part of comprehensive legislation that would permit the Department of Veterans Affairs to expand its assistance to family members of veterans generally." The bill calls for rates on a par with "commercial rates for home caregivers" (Tan, 4/21).
› Verified 7 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 61 |
| Hospitalization Rate in facility | 177.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 305.4 |
| Hospitalization Rate: Lower Confidence Limit | 105.9 |
News Archive
In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond Soccio, MD, PhD, and colleagues at the Perelman School of Medicine at the University of Pennsylvania, aim to apply this knowledge to develop personalized approaches to treating diabetes and other metabolic disorders.
"You are what you eat," the saying goes, but is what you eat playing a role in how much you sleep? Sleep, like nutrition and physical activity, is a critical determinant of health and well-being. With the increasing prevalence of obesity and its consequences, sleep researchers have begun to explore the factors that predispose individuals to weight gain and ultimately obesity.
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
The Los Angeles Times: "The House voted 419 to 0 on Wednesday to approve new benefits and financial support for the primary live-in caregivers of seriously wounded veterans who served in the wars in Iraq and Afghanistan. The measure, which would cost about $1.7 billion over five years, is part of comprehensive legislation that would permit the Department of Veterans Affairs to expand its assistance to family members of veterans generally." The bill calls for rates on a par with "commercial rates for home caregivers" (Tan, 4/21).
› Verified 7 days ago
The rate of readmission show you whether patients who were being treated regularly at Southeastern Dialysis Davita Whiteville were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 26.4 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 37.2 |
| Readmission Rate: Lower Confidence Limit | 17.5 |
News Archive
In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond Soccio, MD, PhD, and colleagues at the Perelman School of Medicine at the University of Pennsylvania, aim to apply this knowledge to develop personalized approaches to treating diabetes and other metabolic disorders.
"You are what you eat," the saying goes, but is what you eat playing a role in how much you sleep? Sleep, like nutrition and physical activity, is a critical determinant of health and well-being. With the increasing prevalence of obesity and its consequences, sleep researchers have begun to explore the factors that predispose individuals to weight gain and ultimately obesity.
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
The Los Angeles Times: "The House voted 419 to 0 on Wednesday to approve new benefits and financial support for the primary live-in caregivers of seriously wounded veterans who served in the wars in Iraq and Afghanistan. The measure, which would cost about $1.7 billion over five years, is part of comprehensive legislation that would permit the Department of Veterans Affairs to expand its assistance to family members of veterans generally." The bill calls for rates on a par with "commercial rates for home caregivers" (Tan, 4/21).
› Verified 7 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Southeastern Dialysis Davita Whiteville get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 2.5 (Worse than Expected) |
| SIR: Upper Confidence Limit | 4.46 |
| SIR: Lower Confidence Limit | 1.27 |
News Archive
In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond Soccio, MD, PhD, and colleagues at the Perelman School of Medicine at the University of Pennsylvania, aim to apply this knowledge to develop personalized approaches to treating diabetes and other metabolic disorders.
"You are what you eat," the saying goes, but is what you eat playing a role in how much you sleep? Sleep, like nutrition and physical activity, is a critical determinant of health and well-being. With the increasing prevalence of obesity and its consequences, sleep researchers have begun to explore the factors that predispose individuals to weight gain and ultimately obesity.
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
The Los Angeles Times: "The House voted 419 to 0 on Wednesday to approve new benefits and financial support for the primary live-in caregivers of seriously wounded veterans who served in the wars in Iraq and Afghanistan. The measure, which would cost about $1.7 billion over five years, is part of comprehensive legislation that would permit the Department of Veterans Affairs to expand its assistance to family members of veterans generally." The bill calls for rates on a par with "commercial rates for home caregivers" (Tan, 4/21).
› Verified 7 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Southeastern Dialysis Davita Whiteville's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 54 |
| Transfusion Rate in facility | 57.7 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 122.6 |
| Transfusion Rate: Lower Confidence Limit | 29.8 |
News Archive
In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond Soccio, MD, PhD, and colleagues at the Perelman School of Medicine at the University of Pennsylvania, aim to apply this knowledge to develop personalized approaches to treating diabetes and other metabolic disorders.
"You are what you eat," the saying goes, but is what you eat playing a role in how much you sleep? Sleep, like nutrition and physical activity, is a critical determinant of health and well-being. With the increasing prevalence of obesity and its consequences, sleep researchers have begun to explore the factors that predispose individuals to weight gain and ultimately obesity.
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
The Los Angeles Times: "The House voted 419 to 0 on Wednesday to approve new benefits and financial support for the primary live-in caregivers of seriously wounded veterans who served in the wars in Iraq and Afghanistan. The measure, which would cost about $1.7 billion over five years, is part of comprehensive legislation that would permit the Department of Veterans Affairs to expand its assistance to family members of veterans generally." The bill calls for rates on a par with "commercial rates for home caregivers" (Tan, 4/21).
› Verified 7 days ago
The rate of mortality show you whether patients who were being treated regularly at Southeastern Dialysis Davita Whiteville lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 305 |
| Mortality Rate in facility | 18.3 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 24.1 |
| Mortality Rate: Lower Confidence Limit | 13.7 |
News Archive
In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond Soccio, MD, PhD, and colleagues at the Perelman School of Medicine at the University of Pennsylvania, aim to apply this knowledge to develop personalized approaches to treating diabetes and other metabolic disorders.
"You are what you eat," the saying goes, but is what you eat playing a role in how much you sleep? Sleep, like nutrition and physical activity, is a critical determinant of health and well-being. With the increasing prevalence of obesity and its consequences, sleep researchers have begun to explore the factors that predispose individuals to weight gain and ultimately obesity.
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
The Los Angeles Times: "The House voted 419 to 0 on Wednesday to approve new benefits and financial support for the primary live-in caregivers of seriously wounded veterans who served in the wars in Iraq and Afghanistan. The measure, which would cost about $1.7 billion over five years, is part of comprehensive legislation that would permit the Department of Veterans Affairs to expand its assistance to family members of veterans generally." The bill calls for rates on a par with "commercial rates for home caregivers" (Tan, 4/21).
› Verified 7 days ago
Southeastern Dialysis Davita Whiteville Location: 608 Pecan Lane, Whiteville, North Carolina, 28472 Phone: (910) 642-0233 |
News Archive
In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond Soccio, MD, PhD, and colleagues at the Perelman School of Medicine at the University of Pennsylvania, aim to apply this knowledge to develop personalized approaches to treating diabetes and other metabolic disorders.
"You are what you eat," the saying goes, but is what you eat playing a role in how much you sleep? Sleep, like nutrition and physical activity, is a critical determinant of health and well-being. With the increasing prevalence of obesity and its consequences, sleep researchers have begun to explore the factors that predispose individuals to weight gain and ultimately obesity.
Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms.
Vermillion, Inc., a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.
The Los Angeles Times: "The House voted 419 to 0 on Wednesday to approve new benefits and financial support for the primary live-in caregivers of seriously wounded veterans who served in the wars in Iraq and Afghanistan. The measure, which would cost about $1.7 billion over five years, is part of comprehensive legislation that would permit the Department of Veterans Affairs to expand its assistance to family members of veterans generally." The bill calls for rates on a par with "commercial rates for home caregivers" (Tan, 4/21).
› Verified 7 days ago